U.S. FDA approves first two-drug HIV regimen from GSK

NEW YORK (Reuters) - The U.S. Food and Drug Administration on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed at lessening the side effect burden of current treatments that combine three or four medicines.